Fosribnicotinamide
Product Sizes
10 mg
£ POA
HY-F0004-10MG
5 mg
£ POA
HY-F0004-5MG
100 mg
£ POA
HY-F0004-100MG
50 mg
£ POA
HY-F0004-50MG
10mM/1mL
£ POA
HY-F0004-10MM
About this Product
- SKU:
- HY-F0004
- Additional Names:
- β-Nicotinamide mononucleotide; β-NM; NMN
- CAS Number:
- 1094-61-7
- Extra Details:
- Fosribnicotinamide (β-nicotinamide mononucleotide) is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and a key NAD+ intermediate. The pharmacological activities of Fosribnicotinamide include its role in cellular biochemical functions; cardioprotection; diabetes; Alzheimer's disease; and complications associated with obesity[1].
- Molecular Weight:
- 334.22
- Purity:
- 99.94
- References:
- [1]Poddar SK, et al. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule. Biomolecules. 2019;9(1):34. Published 2019 Jan 21.|[2]Lv H, et al. NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion [published online ahead of print, 2020 Nov 3]. Cell Metab. 2020;S1550-4131(20)30554-4.|[3]Li J, et al. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Proc Natl Acad Sci U S A. 2019;116(39):19626-19634.|[4]Yoshino J, et al Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528-536.
- Research Area:
- Cancer; Neurological Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; protect from light)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Metabolic Enzyme/Protease
